A drug interaction study to evaluate the effect of RAVICTI on the pharmacokinetics of a drug that is a substrate of cytochrome 3A4 in healthy volunteers

Trial Profile

A drug interaction study to evaluate the effect of RAVICTI on the pharmacokinetics of a drug that is a substrate of cytochrome 3A4 in healthy volunteers

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2015

At a glance

  • Drugs Glycerol phenylbutyrate (Primary)
  • Indications Inborn urea cycle disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 12 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top